المؤلفون: Soule SE; Hoosier Oncology Group, Walther Cancer Institute and Division of Hematology/Oncology, Indiana University, Indianapolis, IN, USA. shsoule@iupui.edu, Miller KD, Porcu P, Ansari R, Fata F, McClean JW, Zon R, Sledge GW, Einhorn LH

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2002 Oct; Vol. 13 (10), pp. 1612-5.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Taxoids*, Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy , Paclitaxel/*analogs & derivatives, Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/pathology ; Docetaxel ; Drug Administration Schedule ; Estramustine/administration & dosage ; Female ; Humans ; Microtubules/physiology ; Middle Aged ; Neoplasm Metastasis ; Paclitaxel/administration & dosage ; Survival ; Treatment Outcome ; Venous Thrombosis/chemically induced

المؤلفون: Miller KD; Department of Medicine, Indiana University Medical Center, Indianapolis, USA., Loehrer PJ, Gonin R, Weber G, Ansari R, Pletcher W, McClean J, Spiridonidis CH, Mortimer J

المصدر: Investigational new drugs [Invest New Drugs] 1996; Vol. 14 (2), pp. 207-12.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print Cited Medium: Print ISSN: 0167-6997 (Print) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*drug therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Hepatocellular/*drug therapy , Liver Neoplasms/*drug therapy , Pancreatic Neoplasms/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Female ; Humans ; Male ; Methotrexate/administration & dosage ; Methotrexate/adverse effects ; Middle Aged ; Remission Induction ; Zidovudine/administration & dosage ; Zidovudine/adverse effects